Vision Risks Associated with GLP-1 Medications Under Investigation Click to Enlarge A recent study published in JAMA Ophthalmology highlights potential vision risks associated with GLP-1 medications such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound). Conducted by researchers, including a neurologist from the University at Buffalo, the study
Insurance Payment Issues? Elevate Your Practice with MSSNY’s Physician Payment and Practice Service Click to Enlarge MSSNY’s Physician Payment and Practice Services are your trusted partner in overcoming healthcare's administrative and financial hurdles. With a proven track record of recouping millions for members, our service
Punching Above Our Weight Click to Enlarge Colleagues: This has been a big week for our lobbying efforts. Kudos to all who came to DC for the AMA National Advocacy Conference or visited Albany the same days for the Budget Hearings. I would like to
